Titre : Facteurs de croissance fibroblastique

Facteurs de croissance fibroblastique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Child Development
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Facteurs de croissance fibroblastique : Questions médicales les plus fréquentes", "headline": "Facteurs de croissance fibroblastique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Facteurs de croissance fibroblastique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-23", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Facteurs de croissance fibroblastique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines et peptides de signalisation intercellulaire", "url": "https://questionsmedicales.fr/mesh/D036341", "about": { "@type": "MedicalCondition", "name": "Protéines et peptides de signalisation intercellulaire", "code": { "@type": "MedicalCode", "code": "D036341", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 1", "alternateName": "Fibroblast Growth Factor 1", "url": "https://questionsmedicales.fr/mesh/D016220", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 1", "code": { "@type": "MedicalCode", "code": "D016220", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.110" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 2", "alternateName": "Fibroblast Growth Factor 2", "url": "https://questionsmedicales.fr/mesh/D016222", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 2", "code": { "@type": "MedicalCode", "code": "D016222", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.120" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 3", "alternateName": "Fibroblast Growth Factor 3", "url": "https://questionsmedicales.fr/mesh/D051518", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 3", "code": { "@type": "MedicalCode", "code": "D051518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.130" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 4", "alternateName": "Fibroblast Growth Factor 4", "url": "https://questionsmedicales.fr/mesh/D051519", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 4", "code": { "@type": "MedicalCode", "code": "D051519", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.140" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 5", "alternateName": "Fibroblast Growth Factor 5", "url": "https://questionsmedicales.fr/mesh/D051521", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 5", "code": { "@type": "MedicalCode", "code": "D051521", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.150" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 6", "alternateName": "Fibroblast Growth Factor 6", "url": "https://questionsmedicales.fr/mesh/D051522", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 6", "code": { "@type": "MedicalCode", "code": "D051522", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.160" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 7", "alternateName": "Fibroblast Growth Factor 7", "url": "https://questionsmedicales.fr/mesh/D051523", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 7", "code": { "@type": "MedicalCode", "code": "D051523", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.170" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 8", "alternateName": "Fibroblast Growth Factor 8", "url": "https://questionsmedicales.fr/mesh/D051524", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 8", "code": { "@type": "MedicalCode", "code": "D051524", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.180" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 9", "alternateName": "Fibroblast Growth Factor 9", "url": "https://questionsmedicales.fr/mesh/D051525", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 9", "code": { "@type": "MedicalCode", "code": "D051525", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.190" } } }, { "@type": "MedicalWebPage", "name": "Facteur de croissance fibroblastique de type 10", "alternateName": "Fibroblast Growth Factor 10", "url": "https://questionsmedicales.fr/mesh/D051526", "about": { "@type": "MedicalCondition", "name": "Facteur de croissance fibroblastique de type 10", "code": { "@type": "MedicalCode", "code": "D051526", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.624.200" } } } ], "about": { "@type": "MedicalCondition", "name": "Facteurs de croissance fibroblastique", "alternateName": "Fibroblast Growth Factors", "code": { "@type": "MedicalCode", "code": "D005346", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "David M Ornitz", "url": "https://questionsmedicales.fr/author/David%20M%20Ornitz", "affiliation": { "@type": "Organization", "name": "Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, United States. Electronic address: dornitz@wustl.edu." } }, { "@type": "Person", "name": "Orson W Moe", "url": "https://questionsmedicales.fr/author/Orson%20W%20Moe", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA." } }, { "@type": "Person", "name": "Jennelle Smith", "url": "https://questionsmedicales.fr/author/Jennelle%20Smith", "affiliation": { "@type": "Organization", "name": "Department of Anatomy and Cell Biology, McGill University, Montreal, QC, H3A 2B2, Canada; Research Institute of the McGill University Health Centre at Glen Site, Montreal, QC, H4A 3J1, Canada." } }, { "@type": "Person", "name": "Loydie A Jerome-Majewska", "url": "https://questionsmedicales.fr/author/Loydie%20A%20Jerome-Majewska", "affiliation": { "@type": "Organization", "name": "Department of Anatomy and Cell Biology, McGill University, Montreal, QC, H3A 2B2, Canada; Department of Human Genetics, McGill University, Montreal, QC, H3A 0G1, Canada; Research Institute of the McGill University Health Centre at Glen Site, Montreal, QC, H4A 3J1, Canada; Department of Paediatrics, McGill University, Montreal, QC, H4A 3J1, Canada. Electronic address: loydie.majewska@mcgill.ca." } }, { "@type": "Person", "name": "Ming Yang", "url": "https://questionsmedicales.fr/author/Ming%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Surgery, University of Missouri, Columbia, MO 65212, United States." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[Analysis of the influence of the timing of enrollment in daycares on child development].", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37075341", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/0102-311XPT150622" } }, { "@type": "ScholarlyArticle", "name": "[The role of ω-3 polyunsaturated fatty acids in child development].", "datePublished": "2024-02-01", "url": "https://questionsmedicales.fr/article/38809795", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.33029/0042-8833-2024-93-2-6-18" } }, { "@type": "ScholarlyArticle", "name": "The intersection of undernutrition, microbiome, and child development in the first years of life.", "datePublished": "2023-06-15", "url": "https://questionsmedicales.fr/article/37322020", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-023-39285-9" } }, { "@type": "ScholarlyArticle", "name": "Environmental contaminants and child development: Developmentally-informed opportunities and recommendations for integrating and informing child environmental health science.", "datePublished": "2022-08-30", "url": "https://questionsmedicales.fr/article/36040401", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cad.20479" } }, { "@type": "ScholarlyArticle", "name": "Interventions for child development based on the Touchpoints Model: scoping review.", "datePublished": "2023-10-09", "url": "https://questionsmedicales.fr/article/37820222", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1518-8345.6732.4034" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Protéines et peptides de signalisation intercellulaire", "item": "https://questionsmedicales.fr/mesh/D036341" }, { "@type": "ListItem", "position": 4, "name": "Facteurs de croissance fibroblastique", "item": "https://questionsmedicales.fr/mesh/D005346" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Facteurs de croissance fibroblastique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Facteurs de croissance fibroblastique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Facteurs de croissance fibroblastique", "description": "Comment diagnostiquer une carence en FGF ?\nQuels tests sont utilisés pour mesurer les niveaux de FGF ?\nQuels symptômes indiquent un déséquilibre en FGF ?\nLes niveaux de FGF varient-ils selon l'âge ?\nComment les maladies affectent-elles les niveaux de FGF ?", "url": "https://questionsmedicales.fr/mesh/D005346?mesh_terms=Child+Development&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Facteurs de croissance fibroblastique", "description": "Quels sont les symptômes d'une surproduction de FGF ?\nLes symptômes de carence en FGF sont-ils spécifiques ?\nComment la cicatrisation est-elle affectée par les FGF ?\nLes douleurs articulaires peuvent-elles être liées aux FGF ?\nQuels signes cliniques sont associés aux FGF ?", "url": "https://questionsmedicales.fr/mesh/D005346?mesh_terms=Child+Development&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Facteurs de croissance fibroblastique", "description": "Comment prévenir les déséquilibres en FGF ?\nLes exercices physiques influencent-ils les niveaux de FGF ?\nY a-t-il des aliments bénéfiques pour les FGF ?\nLe stress affecte-t-il les niveaux de FGF ?\nLes habitudes de sommeil influencent-elles les FGF ?", "url": "https://questionsmedicales.fr/mesh/D005346?mesh_terms=Child+Development&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Facteurs de croissance fibroblastique", "description": "Quels traitements ciblent les FGF ?\nLes FGF sont-ils utilisés en médecine régénérative ?\nComment les FGF sont-ils administrés en traitement ?\nY a-t-il des effets secondaires aux traitements par FGF ?\nLes FGF peuvent-ils être utilisés pour traiter des cancers ?", "url": "https://questionsmedicales.fr/mesh/D005346?mesh_terms=Child+Development&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Facteurs de croissance fibroblastique", "description": "Quelles complications peuvent survenir avec des niveaux anormaux de FGF ?\nLes anomalies de croissance sont-elles une complication des FGF ?\nLes maladies cardiovasculaires sont-elles liées aux FGF ?\nLes troubles de cicatrisation sont-ils une complication des FGF ?\nLes cancers peuvent-ils être exacerbés par des FGF ?", "url": "https://questionsmedicales.fr/mesh/D005346?mesh_terms=Child+Development&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Facteurs de croissance fibroblastique", "description": "Quels facteurs de risque influencent les niveaux de FGF ?\nLe tabagisme affecte-t-il les niveaux de FGF ?\nL'obésité est-elle un facteur de risque pour les FGF ?\nLes maladies métaboliques influencent-elles les FGF ?\nLe vieillissement affecte-t-il les niveaux de FGF ?", "url": "https://questionsmedicales.fr/mesh/D005346?mesh_terms=Child+Development&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en FGF ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour mesurer les niveaux de FGF ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des dosages immunologiques spécifiques peuvent être utilisés pour mesurer les niveaux de FGF." } }, { "@type": "Question", "name": "Quels symptômes indiquent un déséquilibre en FGF ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, la cicatrisation lente et des anomalies de croissance peuvent indiquer un déséquilibre." } }, { "@type": "Question", "name": "Les niveaux de FGF varient-ils selon l'âge ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux de FGF peuvent varier avec l'âge et le développement physiologique." } }, { "@type": "Question", "name": "Comment les maladies affectent-elles les niveaux de FGF ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies, comme le diabète, peuvent altérer la production de FGF, affectant la guérison." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une surproduction de FGF ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction peut entraîner des anomalies de croissance et des troubles métaboliques." } }, { "@type": "Question", "name": "Les symptômes de carence en FGF sont-ils spécifiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils peuvent être non spécifiques et imiter d'autres conditions médicales." } }, { "@type": "Question", "name": "Comment la cicatrisation est-elle affectée par les FGF ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les FGF stimulent la prolifération cellulaire, accélérant ainsi le processus de cicatrisation." } }, { "@type": "Question", "name": "Les douleurs articulaires peuvent-elles être liées aux FGF ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres en FGF peuvent contribuer à des douleurs articulaires et à l'inflammation." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés aux FGF ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'œdème, la fibrose et des anomalies de croissance peuvent être observés." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres en FGF ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir des niveaux de FGF adéquats." } }, { "@type": "Question", "name": "Les exercices physiques influencent-ils les niveaux de FGF ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut augmenter la production de FGF et améliorer la santé tissulaire." } }, { "@type": "Question", "name": "Y a-t-il des aliments bénéfiques pour les FGF ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des aliments riches en antioxydants et en vitamines peuvent soutenir la production de FGF." } }, { "@type": "Question", "name": "Le stress affecte-t-il les niveaux de FGF ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber la production de FGF et affecter la santé globale." } }, { "@type": "Question", "name": "Les habitudes de sommeil influencent-elles les FGF ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un sommeil de qualité est crucial pour la régulation hormonale, y compris les FGF." } }, { "@type": "Question", "name": "Quels traitements ciblent les FGF ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des médicaments biologiques peuvent cibler les FGF pour traiter diverses conditions." } }, { "@type": "Question", "name": "Les FGF sont-ils utilisés en médecine régénérative ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les FGF sont utilisés pour favoriser la régénération des tissus dans la médecine régénérative." } }, { "@type": "Question", "name": "Comment les FGF sont-ils administrés en traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être administrés par injection locale ou systémique, selon l'indication clinique." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements par FGF ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des réactions allergiques ou des inflammations peuvent survenir." } }, { "@type": "Question", "name": "Les FGF peuvent-ils être utilisés pour traiter des cancers ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines thérapies ciblant les FGF sont explorées pour traiter des cancers en inhibant leur action." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des niveaux anormaux de FGF ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles métaboliques, des maladies cardiovasculaires peuvent survenir." } }, { "@type": "Question", "name": "Les anomalies de croissance sont-elles une complication des FGF ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de FGF peuvent entraîner des anomalies de croissance chez les enfants." } }, { "@type": "Question", "name": "Les maladies cardiovasculaires sont-elles liées aux FGF ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres en FGF peuvent contribuer à des maladies cardiovasculaires et à l'athérosclérose." } }, { "@type": "Question", "name": "Les troubles de cicatrisation sont-ils une complication des FGF ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux insuffisants de FGF peuvent entraîner des troubles de cicatrisation et des infections." } }, { "@type": "Question", "name": "Les cancers peuvent-ils être exacerbés par des FGF ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surproduction de FGF peut favoriser la progression de certains types de cancers." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent les niveaux de FGF ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, l'alimentation, le stress et les maladies chroniques influencent les niveaux de FGF." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il les niveaux de FGF ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut réduire la production de FGF et affecter la santé tissulaire." } }, { "@type": "Question", "name": "L'obésité est-elle un facteur de risque pour les FGF ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité peut perturber la régulation des FGF et augmenter le risque de maladies associées." } }, { "@type": "Question", "name": "Les maladies métaboliques influencent-elles les FGF ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent altérer la production et l'action des FGF." } }, { "@type": "Question", "name": "Le vieillissement affecte-t-il les niveaux de FGF ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut entraîner une diminution des niveaux de FGF, affectant la régénération tissulaire." } } ] } ] }

Sources (10000 au total)

Environmental contaminants and child development: Developmentally-informed opportunities and recommendations for integrating and informing child environmental health science.

Child environmental health (CEH) science has identified numerous effects of early life exposures to common, ubiquitous environmental toxicants. CEH scientists have documented the costs not only to ind...

Interventions for child development based on the Touchpoints Model: scoping review.

to map the characteristics of interventions to promote child development that used the Touchpoints Model.... this is a scoping review, guided by the recommendations of the JBI Reviewer's Manual, carried out in nine databases, in the gray literature and in the reference list of the selected studies. The resea... twelve publications were included in the review. Interventions were heterogeneous; concentrated in the period from pregnancy to three years of age; prioritized the dissemination of Touchpoints content... studies have shown potential for favorable outcomes for child development and parenting. The variability of interventions made it difficult to map more effective characteristics. (1) Interventions in ...

Specialist care of children with complex needs: Insights from comparison of child development and child mental health clinics.

Paediatricians and child psychiatrists review children with complex comorbidity, noting similarities between tertiary Child Development Service (CDS) and Child and Youth Mental Health Service (CYMHS) ... A questionnaire was completed by parents of CDS and CYMHS new clients aged 4-11. It included measures of mental health symptoms, child development, physical health, stressful life events, family funct... The study population had elevated rates of psychosocial risk, family dysfunction, physical illness, developmental risk and mental health symptoms. CDS had higher levels of developmental risk and famil... Consideration should be given to mental health screening and support in CDS, and to developmental screening in CYMHS. Both services support at-risk children with complex developmental, mental health a...

Clinical validation of the nursing diagnosis "Risk for delayed child development".

To validate clinically the risk factors of the nursing diagnosis "Risk for delayed child development".... Cross-sectional quantitative study carried out in a specialty outpatient clinic and in family health units with 124 children. The data was collected through interviews with the children's guardians to... The tested risk factors affected 108 of the evaluated children (87.1%). In the accuracy tests, most specificity values were above 80% and sensitivity values were lower than 30%. Most risk factors had ... The study contributed to a refined diagnostic accuracy, identifying potential associated factors of the evaluated diagnosis....

Educational interventions in child development and health literacy assumptions: an integrative review.

to analyze scientific evidence in the literature that addresses educational interventions conducted by health professionals on early childhood development in a community context and to identify which ... an integrative review in PubMed, CINAHL and Web of Science databases. Of 300 studies found, we selected 11 for the sample.... health professionals are trained to implement interventions with parents/caregivers to promote child development in community settings. Parents are encouraged to develop an environment that is encoura... it confirms the importance of training health professionals, with skills and communicative skills to guide parents/caregivers to encourage the development of their children in their family environment...